On January 21, Gelonghui Announced that 300633.SZ it expects net profit attributable to shareholders of listed companies in 2021 to be 205 million yuan - 255 million yuan, compared with a loss of 46.2631 million yuan in the same period last year; net profit after deducting non-recurring gains and losses of 172 million yuan - 222 million yuan, compared with a loss of 90.3422 million yuan in the same period last year. The reasons for the change in performance are as follows:
1. During the reporting period, the company's various businesses conformed to the development plan formulated at the beginning of the year, the ultrasound business grew steadily, the endoscopic business maintained a high growth rate, with the normalization of the epidemic, the foreign business improved significantly compared with the same period last year, and the overall realization of the company's revenue increased significantly, and the net profit performance was better. In 2021, the company's revenue scale hit a record high, representing the company's "ultrasound + endoscopy" two-legged walking strategy is becoming more and more mature, and the company's operation is becoming more and more stable. With the technical advantages in the field of ultrasound and endoscopy, the company actively explores new products and new fields, and the product applications are expanded from ultrasound and gastroenterology to surgery and respiratory medicine, and the company's multi-product strategy has begun to take shape.
2. During the reporting period, the impact of the provision for impairment of goodwill on net profit is expected to be 15-30 million yuan.
3. The arbitration between the company and Huang Xin, the former shareholder of Shanghai Wilson Optoelectronic Instrument Co., Ltd., is still in the process of trial, and the company cannot predict the final result.
4. During the reporting period, the impact of non-recurring gains and losses on the net profit attributable to the parent company is expected to be 33 million yuan, mainly for the government subsidy funds obtained by the company, the income from wealth management products, etc., and the impact of non-recurring gains and losses on the net profit attributable to the parent company in the same period last year was 44.08 million yuan.
This article originated from Grand Gateway